Table of Contents As filed with the Securities and Exchange Commission on January 17, 2023 Registration No. 333-268888 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NewAmsterdam Pharma Company N.V. (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of incorporation or organization) The Netherlands 2834 Not Applicable (Primary Standard Industrial Classification Code N ...